泄浊通络法对慢性肾脏病3~5期患者免疫功能的影响
DOI:
作者:
作者单位:

作者简介:

通讯作者:

中图分类号:

R692

基金项目:

广东省教育厅青年创新人才类项目(2018KQNCX043);广东省中医药局面上项目(20191114);广东省高等教育杰出青年人才(自 然科学) 基金(2018KQNCX048)


Effect of Xiezhuo Tongluo Method on Immune Function in Patients with Chronic Kidney Disease at Stage 3 to 5
Author:
Affiliation:

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
  • |
  • 文章评论
    摘要:

    目的:观察泄浊通络法对慢性肾脏病(CKD) 3~5 期患者免疫功能的影响。方法:选取84 例CKD 3~5 期患者,按随机数字表法分为对照组和治疗组,每组42 例;招募20 名健康志愿者作为正常组。对照组给予常规对症治疗,治疗组在对照组基础上给予泄浊通络法治疗,2 组均连续治疗3 个月。正常组不进行治疗。比较3 组治疗前后CD4+、CD8+水平,CD4+/CD8+值,血清白细胞介素-2(IL-2)、可溶性白细胞介素-2 受体(sIL-2R) 水平,免疫球蛋白(Ig) G、IgA、IgM 水平,以及红细胞C3b受体花环率(RBC-C3bRR)、红细胞免疫复合物花环率(RBC-ICR) 水平。结果:治疗前,对照组与治疗组CD4+水平、CD4+/CD8+值均低于正常组(P<0.05),CD8+水平均高于正常组(P<0.05)。治疗后,治疗组CD4+水平、CD4+/CD8+值均较治疗前升高(P<0.05),CD8+水平较治疗前降低(P<0.05);治疗组CD4+水平、CD4+/CD8+值均高于对照组(P<0.05),CD8+水平低于对照组(P<0.05)。治疗前,对照组与治疗组IL-2 水平均低于正常组(P<0.05),sIL-2R 水平均高于正常组(P<0.05)。治疗后,治疗组IL-2 水平较治疗前升高(P<0.05),sIL-2R 水平较治疗前降低(P<0.05);治疗组IL-2 水平高于对照组(P<0.05),sIL-2R 水平低于对照组(P<0.05)。治疗前,对照组与治疗组IgG、IgA、IgM 水平均低于正常组(P<0.05)。治疗后,治疗组IgG、IgA、IgM 水平及对照组IgG 水平均较治疗前升高(P<0.05);治疗组IgG、IgA、IgM 水平均高于对照组(P<0.05)。治疗前,对照组与治疗组RBC-C3bRR 水平均低于正常组(P<0.05)、RBC-ICR 水平均高于正常组(P<0.05)。治疗后,治疗组RBC-C3bRR 水平较治疗前升高(P<0.05),RBC-ICR 水平较治疗前降低(P<0.05);治疗组RBC-C3bRR 水平高于对照组(P<0.05),RBC-ICR 水平低于对照组(P<0.05)。结论:泄浊通络法可改善CKD 3~5 期患者的细胞、体液和红细胞免疫功能。

    Abstract:

    Abstract: Objective: To observe the effect of Xiezhuo Tongluo method on immune function in patients with chronic kidney disease(CKD) at stage 3 to 5. Methods:A total of 84 cases of patients with CKD at stage 3 to 5 were selected and divided into the control group and the treatment group according to the random number table method, 42 cases in each group;a total of 20 healthy volunteers were recruited as the normal group. The control group was given routine symptomatic treatment, and the treatment group was additionally treated with Xiezhuo Tongluo method based on the treatment of the control group; both groups were treated for three months. The normal group was not given treatment. Before and after treatment,the levels of CD4+ and CD8+,the values of CD4+/CD8+,and the levels of interleukin-2(IL-2),soluble interleukin-2 receptor(sIL-2R),immunoglobulin(Ig) G,IgA and IgM in serum,red blood cell-C3b receptor rosette rate(RBC-C3bRR) and red blood cell- immune complex rosette rate(RBC- ICR) in the three groups were compared. Results: Before treatment, CD4+ levels and CD4+/CD8+ values in the control group and the treatment group were lower than those in the normal group(P< 0.05),and CD8+ levels were higher(P<0.05). After treatment,CD4+ level and CD4+/CD8+ value in the treatment group were increased when compared with those before treatment(P<0.05),and CD8 + level was decreased(P<0.05);CD4 + level and CD4+/CD8+ value in the treatment group were higher than those in the control group(P<0.05),and CD8+ level was lower(P< 0.05). Before treatment,IL-2 levels in the control group and the treatment group were lower than those in the normal group (P<0.05),and sIL-2R levels were higher(P<0.05). After treatment,IL-2 level in the treatment group was increased when compared with that before treatment(P<0.05),and sIL-2R level was decreased(P<0.05);IL-2 level in the treatment group was higher than that in the control group(P<0.05), and sIL- 2R level was lower(P<0.05). Before treatment, the levels of IgG,IgA and IgM in the control group and the treatment group were lower than those in the normal group(P<0.05). After treatment,the levels of IgG,IgA and IgM in the treatment group and IgG level in the control group were increased when compared with those before treatment(P<0.05); the levels of IgG, IgA and IgM in the treatment group were higher than those in the control group(P<0.05). Before treatment,the levels of RBC-C3bRR in the control group and the treatment group were lower than that in the normal group(P<0.05),and the levels of RBC- ICR were higher(P<0.05). After treatment,the level of RBC- C3bRR in the treatment group was increased when compared with that before treatment(P<0.05), and the level of RBC- ICR was decreased(P<0.05); the level of RBC- C3bRR in the treatment group was higher than that in the control group(P<0.05),and the level of RBC- ICR was lower(P<0.05). Conclusion:Xiezhuo Tongluo method can improve the immune function of cells,body fluids and red blood cells in patients with CKD at stage 3 to 5.

    参考文献
    相似文献
    引证文献
引用本文

涂海涛,罗苑苑,王亮亮,陈刚毅,鲁欢,汤水福.泄浊通络法对慢性肾脏病3~5期患者免疫功能的影响[J].新中医,2021,53(12):98-102

复制
分享
文章指标
  • 点击次数:
  • 下载次数:
  • HTML阅读次数:
  • 引用次数:
历史
  • 收稿日期:
  • 最后修改日期:
  • 录用日期:
  • 在线发布日期: 2021-06-23
  • 出版日期: